8-K: Jupiter Neurosciences Announces Change in Independent Registered Public Accounting Firm

Jupiter Neurosciences replaces Assurance Dimensions, LLC with Cherry Bekaert LLP as its independent registered public accounting firm, effective April 16, 2025, following AD's decision to discontinue its PCAOB registrants practice.

Summary

• Jupiter Neurosciences, Inc. has changed its independent registered public accounting firm.
• Assurance Dimensions, LLC (AD) resigned, effective April 16, 2025, due to its decision to discontinue its PCAOB registrants practice.
• The Audit Committee approved the engagement of Cherry Bekaert LLP (CB) as the new independent registered public accounting firm, also effective April 16, 2025.
• AD's audit reports for the years ended December 31, 2024 and 2023 did not contain adverse opinions or disclaimers, but disclosed uncertainty regarding the company's ability to continue as a going concern.
• There were no disagreements or reportable events between the Company and AD regarding accounting principles, practices, financial statement disclosure, or auditing scope or procedures.
• The Company did not consult with CB on accounting principles or the type of audit opinion before their engagement.
• AD has reviewed the Company's statements in the Form 8-K and agrees with them.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the change in accounting firm is not inherently negative, the disclosure of uncertainty regarding the company's ability to continue as a going concern is a concern.

Positives

• The transition to a new accounting firm appears to be smooth, with no reported disagreements or reportable events.
• Assurance Dimensions, LLC agrees with the statements made by Jupiter Neurosciences in the Form 8-K.

Negatives

• AD's audit reports for 2024 and 2023 disclosed uncertainty regarding the company's ability to continue as a going concern.

Risks

• The change in accounting firm could potentially lead to increased scrutiny from investors and regulators.
• The uncertainty regarding the company's ability to continue as a going concern, as noted by the previous auditor, remains a concern.

Future Outlook

The document does not contain specific forward-looking statements regarding financial performance or business strategy beyond the change in accounting firm.

Management Comments

• Christer Rosen, Chief Executive Officer, signed the report on behalf of Jupiter Neurosciences, Inc.

Industry Context

Changes in accounting firms are not uncommon, but they can raise concerns if not handled transparently. The reason for the change, AD's decision to discontinue its PCAOB registrants practice, is a valid and understandable reason.

Comparison to Industry Standards

• The process of changing accounting firms appears to follow standard procedures, including approval by the Audit Committee and communication with the SEC.
• It is common practice for the previous accounting firm to provide a letter to the SEC confirming their agreement with the company's statements regarding the change.

Stakeholder Impact

• Shareholders may be concerned about the change in accounting firm and the disclosed uncertainty regarding the company's ability to continue as a going concern.
• Employees may experience uncertainty due to the company's financial situation.

Key Dates

Keywords

accounting firm, Jupiter Neurosciences, Cherry Bekaert LLP, Assurance Dimensions, PCAOB, audit, Form 8-K